BEGIN:VCALENDAR
VERSION:2.0
PRODID:-//Beacon Medical Professionals - ECPv6.18.2//NONSGML v1.0//EN
CALSCALE:GREGORIAN
METHOD:PUBLISH
X-WR-CALNAME:Beacon Medical Professionals
X-ORIGINAL-URL:https://www.beaconhealthsystem.org/medical-professionals
X-WR-CALDESC:Events for Beacon Medical Professionals
REFRESH-INTERVAL;VALUE=DURATION:PT1H
X-Robots-Tag:noindex
X-PUBLISHED-TTL:PT1H
BEGIN:VTIMEZONE
TZID:America/Indiana/Indianapolis
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20250309T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20251102T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20260308T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20261101T060000
END:STANDARD
BEGIN:DAYLIGHT
TZOFFSETFROM:-0500
TZOFFSETTO:-0400
TZNAME:EDT
DTSTART:20270314T070000
END:DAYLIGHT
BEGIN:STANDARD
TZOFFSETFROM:-0400
TZOFFSETTO:-0500
TZNAME:EST
DTSTART:20271107T060000
END:STANDARD
END:VTIMEZONE
BEGIN:VEVENT
DTSTART;VALUE=DATE:20261104
DTEND;VALUE=DATE:20261105
DTSTAMP:20261023T144753Z
CREATED:20261005T193550Z
LAST-MODIFIED:20261023T144753Z
UID:10000495-1793750400-1793836799@www.beaconhealthsystem.org
SUMMARY:Bispecific Antibodies for the Management of Multiple Myeloma: Focus on Managing Toxicities
DESCRIPTION:Click HERE to Access the Teams Link  \nBispecific Antibodies for the Management of Multiple Myeloma: Focus on Managing Toxicities \nPresented By: Ricardo D. Parrondo\, MD\nAssistant Professor of Medicine\nConsultant\, Department of Hematology-Oncology & Bone Marrow Transplantation and Cellular Therapies\, Mayo Clinic \nRicardo D. Parrondo\, M.D.\, is a senior associate consultant in the Division of Hematology/Oncology\, Department of Internal Medicine at Mayo Clinic in Florida. Dr. Parrondo joined the staff of Mayo Clinic in 2018 and holds the academic rank of assistant professor of medicine\, Mayo Clinic College of Medicine and Science.\nDr. Parrondo earned his B.A. at the University of Pennsylvania in Philadelphia and his M.D. at the American University of the Caribbean\, Cupecoy\, Netherlands Antilles. He completed his internal medicine residency at New Jersey Medical School\, Rutgers University in Newark\, New Jersey\, and his hematology/oncology fellowship at Mayo Clinic School of Graduate Medical Education.\nDr. Parrondo has a strong interest in malignant hematology\, hematopoietic stem cell transplantation\, and cellular therapies\, with a particular focus on plasma cell proliferative disorders. He conducts clinical and translational research to advance the treatment and outcomes of patients with plasma cell proliferative disorders. His work includes devising new strategies to improve the therapeutic outcomes of patients with multiple myeloma in addition to gaining a better understanding of the myeloma bone marrow microenvironment. He is also interested in improving the depth and duration of response in patients with multiple myeloma who undergo autologous stem cell transplant. He has authored numerous journal articles and abstracts and serves as a peer reviewer for Hematology/Oncology and Stem Cell Therapy.\nDr. Parrondo is a member of the American Society for Transplantation and Cellular Therapy\, American Society of Clinical Oncology\, American Society of Hematology\,
URL:https://www.beaconhealthsystem.org/medical-professionals/event/bispecific-antibodies-for-the-management-of-multiple-myeloma-focus-on-managing-toxicities/
LOCATION:Auditorium at Memorial Hospital\, 615 N Michigan St\, South Bend\, IN\, 46601\, United States
CATEGORIES:CME Events,Grand Rounds
END:VEVENT
END:VCALENDAR